栓塞市場：按產品類型、按適應症、按最終用戶、按地區

2024年全球栓塞市場價值為22.1億美元，預計2031年將達到38.8億美元，2024年至2031年的複合年成長率為8.4%。

圖 1. 2024 年栓塞市場佔有率(%)，依地區分類

栓塞是一種微創手術，可阻斷一條或多條動脈或靜脈。它通常用於治療腫瘤、血管畸形和動脈瘤等疾病。栓塞涉及將一根稱為導管的細長管插入動脈或靜脈，並將其穿過循環系統到達目標部位。根據所治療的疾病，可剝離線圈、酒精、明膠海綿或珠子等栓塞材料經由導管輸送以阻止血流。這種尖端治療方法是開放性手術的替代方案，具有更少的疼痛、疤痕、恢復時間和費用。栓塞擴大用於各種治療和診斷，推動了全球栓塞市場的成長。

市場動態：

由於癌症、血管疾病和創傷等各種目標疾病的盛行率不斷上升，全球栓塞市場正在顯著成長。越來越多的老年人更容易受到這種情況的影響，這是市場成長的推動力。栓塞治療設備的技術進步、生物活性栓塞劑的引入以及微創手術優於開放性手術的偏好為市場參與者提供了利潤豐厚的機會。然而，某些地區對新產品認證的嚴格監管要求、高成本以及缺乏熟練的專業人員可能會阻礙市場成長。市場參與企業為傳播栓塞意識和開拓先進栓塞材料所做的各種努力預計將有助於在不久的將來克服這些限制。

本研究的主要特點

• 本報告對全球栓塞市場進行了詳細分析，並提出了以2023年為基準年的預測期（2024-2031）的市場規模和年複合成長率（CAGR%）。
• 它還揭示了各個細分市場的潛在商機，並說明了該市場有吸引力的投資提案矩陣。
• 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
• 它根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球栓塞市場的主要企業。
• 該報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
• 全球栓塞市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
• 相關人員可以透過用於全球栓塞市場分析的各種策略矩陣來促進他們的決策。

目錄

第1章 研究目的與前提

• 研究目標
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章 市場動態、法規與趨勢分析

• 市場動態
  • 促進因素
  • 抑制因素
  • 機會
• 影響分析
• 市場趨勢
• 主要進展
• 監管場景
• 收購和合作場景
• 資金籌措和投資
• PEST分析
• 波特的分析

第4章全球栓塞市場 - 冠狀病毒（COVID-19）大流行的影響

• 整體影響
• 政府舉措
• COVID-19 對市場的影響

第5章 全球栓塞市場：依產品類型分類，2019-2031（十億美元）

• 粒子
• 放射栓塞球
• 藥物釋放型珠
• 微球（或無藥品牌珠）
• PVA顆粒（聚乙烯醇）
• 液體栓塞
• 插頭
• 線圈

第6章 全球栓塞市場：依跡象分類，2019-2031 年（十億美元）

• 流血的
• 良性攝護腺增生（BPH）
• 子宮肌瘤
• 腫瘤（包括惡性、肝癌）
• 畸形（AVM、AVF）
• 靜脈栓塞
• 其他

第 7 章 全球栓塞市場：以最終用戶分類，2019-2031 年（十億美元）

• 醫院/診所
• 門診手術中心
• 其他

第8章 全球栓塞市場：按地區分類，2019-2031（十億美元）

• 拉丁美洲
• 歐洲
• 亞太地區
• 中東

第9章 競爭格局

• 公司簡介
  • Stryker Corporation
  • Medtronic plc
  • Boston Scientific Corporation
  • Johnson &Johnson（Cerenovis）
  • Terumo Corporation
  • Cook Medical
  • B. Braun Melsungen AG
  • Penumbra, Inc.
  • BTG plc
  • Merit Medical Systems
  • Pfizer Inc.
  • Abbott Laboratories
  • Acandis GmbH &Co. KG
  • Blockade Medical LLC
  • MicroPort Scientific Corporation
  • Kaneka Corporation
  • Galt Medical

第10章分析師建議

• 命運之輪
• 分析師觀點
• Coherent Opportunity Map

第11章 參考文獻與調查方法

• 參考
• 調查方法

Global embolization market is estimated to be valued at USD 2.21 Bn in 2024 and is expected to reach USD 3.88 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.4% from 2024 to 2031.

Figure 1. Embolization Market Share (%), By Region, 2024

Embolization is a minimally invasive procedure that blocks one or more arteries or veins. It is commonly used to treat medical conditions such as tumors, vascular malformations, and aneurysms. Embolization uses slender tubes called catheters, which are inserted into an artery or vein and then threaded through the circulatory system to the target site. Depending on the condition being treated, embolic materials such as detachable coils, alcohol, gelatin sponges, or beads are delivered through the catheter to block the blood flow. This cutting-edge therapy provides an alternative to open surgery and is associated with less pain, scarring, recovery time, and costs. Embolization is increasingly employed for various therapeutic and diagnostic procedures, thus, driving the global embolization market growth.

Market Dynamics:

Global embolization market is witnessing significant growth due to rising prevalence of various target conditions such as cancer, vascular diseases, and traumatic injuries. Growing geriatric population who are more prone to such conditions can drive the market growth. Technological advancements in embolization devices, introduction of bioactive embolization agents, and preference for minimally invasive procedures over open surgeries offers lucrative opportunities for market players. However, strict regulatory requirements for new product approval, high costs involved, and lack of skilled professionals in some regions can hamper the market growth. Various initiatives by market players to spread awareness about embolization therapy and development of advanced embolization materials can help overcome these restraints in the near future.

Key Features of the Study:

• This report provides in-depth analysis of the global embolization market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global embolization market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Boston Scientific Corp, Terumo Corporation, Medtronic plc, Stryker Corporation, and Abbott Laboratories.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• Global embolization market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global embolization market.

Detailed Segmentation-

• By Product Type:
  • Particles
  • Radioembolization Spheres
  • Drug-Eluting Bead
  • Microspheres (or Blands beads, without drug)
  • PVA Particles (Polyvinyl Alcohol)
  • Liquid Embolic
  • Plugs
  • Coils
• By Indication
  • Hemorrhage/Bleeding
  • Benign Prostatic Hyperplasia (BPH)
  • Uterine Fibroid
  • Tumor (Malignant, including Liver Cancer)
  • Malformation (AVM, AVF)
  • Venous embolization
  • Others
• By End User
  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Others
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Stryker Corporation
  • Medtronic plc
  • Boston Scientific Corporation
  • Johnson & Johnson (Cerenovis)
  • Terumo Corporation
  • Cook Medical
  • Braun Melsungen AG
  • Penumbra, Inc.
  • BTG plc
  • Merit Medical Systems
  • Pfizer Inc.
  • Abbott Laboratories
  • Acandis GmbH & Co. KG
  • Blockade Medical LLC
  • MicroPort Scientific Corporation
  • Kaneka Corporation
  • Galt Medical

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product Type
  • Market Snapshot, By Indication
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Embolization Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Embolization Market, By Product Type, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2019 - 2031
  • Segment Trends
• Particles
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Radioembolization Spheres
• Drug-Eluting Bead
• Microspheres (or Blands beads, without drug)
• PVA particles (Polyvinyl Alcohol)
• Liquid Embolic
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Plugs
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Coils
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Embolization Market, By Indication, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2019 - 2031
  • Segment Trends
• Hemorrhage/Bleeding
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Benign Prostatic Hyperplasia (BPH)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Uterine Fibroid
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Tumor (Malignant, including Liver Cancer)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Malformation (AVM, AVF)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Venous embolization
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Embolization Market, By End User, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2019 - 2031
  • Segment Trends
• Hospitals & Clinics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Ambulatory Surgical Centers
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Embolization Market, By Region, 2019 - 2031, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, For Region, 2019-2031
  • Regional Trends
    • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profiles
  • Stryker Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Medtronic plc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Boston Scientific Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Johnson & Johnson (Cerenovis)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Terumo Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Cook Medical
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • B. Braun Melsungen AG
  • Penumbra, Inc.
  • BTG plc
  • Merit Medical Systems
  • Pfizer Inc.
  • Abbott Laboratories
  • Acandis GmbH & Co. KG
  • Blockade Medical LLC
  • MicroPort Scientific Corporation
  • Kaneka Corporation
  • Galt Medical

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact